secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2026-10-02T20:33:26+00:00
Accession:  0001437749-26-031895
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Catheter Precision becomes Flyte Aviation with 1-for-10 reverse split Oct 5; ticker switches to VJET
--------------------------------------------------------------------------------

- Stockholders approved the 1-for-10 reverse split and name change to Flyte Aviation, Inc.; shares drop from ~21,019,874 to ~2,101,987, trading as VJET on NYSE American from Oct 5, 2026.
- Option repricing approved: options struck above fair market value repriced to $0.152/share (Sept 30 close), $1.52 post-split; CEO Jenkins held 89,999 options, CFO Anderson 66,315.
- 2023 Equity Incentive Plan amended to add 5,000,000 shares; stockholders also cleared issuance of up to 340,000 shares on Series M warrants and a Series J preferred conversion-price cut (floor $0.23).
- David A. Jenkins elected Class II director (9,640,603 for vs 301,162 withheld) for a term to 2029; WithumSmith+Brown ratified as auditor for FY2027.
- Reincorporation from Delaware to Nevada by plan of conversion approved; authorized capital unchanged at 500M common and 10M preferred shares. No fractional shares; Equiniti is exchange agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000143774926031895/0001437749-26-031895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000143774926031895/vtak20261002_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-031895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer